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Abstract
Background: There are evidence-based interventions for depression that include different components. However,
the efficacy of their therapeutic components is unknown. Another important issue related to depression interventions
is that, up to now, their therapeutic components have only focused on reducing negative symptoms rather than on
improving positive affect and well-being. Because the low levels of positive affect are more strongly linked to
depression than to other emotional disorders, it is important to include this variable as an important treatment
target. Positive psychotherapeutic strategies (PPs) could help in this issue. The results obtained so far
are consistent and promising, showing that Internet-based interventions are effective in treating
depression. However, most of them are also multi-component, and it is important to make progress in investigating
what each component contributes to the intervention.
Methods: The current study will be a three-armed, simple-blinded, randomized controlled clinical trial with a dismantling
design. 192 participants will be randomly assigned to: a) an Internet-based Global Protocol condition, which includes
traditional therapeutic components of evidence-based treatments for depression (Motivation for change,
Psychoeducation, Cognitive Therapy, Behavioral Activation (BA), Relapse Prevention) and PPs component, offering
strategies to enhance positive mood and promote psychological strengths; b) an Internet-based BA Protocol condition
(without the PPs component), and c) an Internet-based PPs Protocol condition (without the BA component). Primary
outcome measures will be the BDI-II and PANAS. Secondary outcomes will include other variables such as depression,
anxiety and stress, quality of life, resilience, and wellbeing related measures. Treatment acceptance and usability will
also be measured. Participants will be assessed at pre-, post-treatment, 3-, 6- and 12- month follow- ups. The data will
be analyzed based on the Intention-to-treat principle. Per protocol analyses will also be performed.
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Discussion: To the best of our knowledge, this is the first randomized dismantling intervention study for depression
with the aim of exploring the contribution of a PPs component and the BA component in an Internet-based
intervention. The three protocols are online interventions, helping to reach many people who need psychological
treatments and otherwise would not have access to them.
Trial registration: Clinicalstrials.gov as NCT03159715. Registered 19 May 2017.
Keywords: Depression, Behavioral activation, Components, Randomized controlled dismantling study, Internet-based
intervention, positive psychotherapy
Background
Major depression is projected to become the largest con-
tributor to the disease burden in high income nations by
2030 [1, 2]. Hundreds of controlled and comparative stu-
dies have examined the efficacy of psychological treatments
for depression [3, 4]. Thus, we have evidence-based inter-
ventions for depression, including cognitive behavior ther-
apy (CBT) [5, 6] and behavioral activation (BA) [7, 8], as
well as interpersonal [3, 9] or problem-solving therapy [10].
Of all of them, CBT has been extensively researched as an
intervention for patients with depression. Studies have
shown robust evidence of its efficacy [3, 11–13]. Further-
more, the effect sizes found for CBT have been large com-
pared to waiting list, placebo, or no-treatment conditions
[14]. It usually consists of applied cognitive techniques to
change thought patterns and behavioral techniques to acti-
vate behaviors [13]. However, the efficacy of its therapeutic
components is unknown [15]. The literature shows that BA
is an essential component of CBT treatments for depres-
sion [16–18]. Meta-analyses show that the effects of BA
treatment on depressive symptoms are maintained or even
improve at 6- and 12-month follow-ups, compared to
control conditions and other treatments [7]. Nevertheless,
less is known about how depression therapies work and the
mechanisms that are responsible for their effects [19, 20].
The US Institute of Medicine indicated that a key step in
being able to offer evidence-based interventions in clinical
settings is the identification of the core elements of psycho-
logical interventions [21]. It has been pointed out that
component studies are the best design to examine these
core elements [15].
Another important issue related to depression interven-
tions is that, until recently, their therapeutic components
focused solely on improving negative symptoms (depres-
sive symptoms, anxiety, etc.), and not on the promotion of
positive affect, well-being, and character strengths [22].
Positive psychotherapeutic strategies (PPs) work to help in
this issue by promoting positive functioning [22]. The main
PPs are Well-being Therapy [23–26], which improves
well-being dimensions based on Ryff ’s model of eudaimo-
nic well-being [27]; Quality of Life therapy [28, 29], which
is more focused on promoting hedonic well-being and life
satisfaction in various significant life domains; and Positive
Psychotherapy [30, 31], focused on alleviating suffering and
systematically enhance happiness by building positive emo-
tions, strengths, and meaning in patients’ lives; and
Strengths based Counseling [32, 33]. These interventions
have been tested in clinical populations, particularly in
depressed patients [34, 35]. They are effective in the im-
provement of depression and well-being [36, 37]. It has
been established in the literature that depressive
symptoms are related to lack of meaning in life and
low levels of positive emotions, and that depression is
more associated with low levels of positive affect than
other emotional disorders [38]. Most of the positive
interventions promote positive affect, gratitude, resi-
lience, and positive functioning [22], and different
studies have pointed out the importance of taking
these variables into account as important depression
intervention targets [39, 40].
Because depression is a prevalent mental disorder, one
of the principal challenges nowadays is to develop new
ways to deliver psychological interventions in order to
maximize their efficiency and dissemination [41, 42].
Several internationally well-known research groups have
launched Internet-based programs in an attempt to
address this issue. Results obtained so far show that
these online programs are effective in treating depres-
sion [3, 43–47]. However, as in the case of face-to-face
interventions, most of the Internet-based intervention
programs for depression are also multi-component, and
it is important to make progress in investigating what
each component brings to the intervention.
As mentioned above, component studies are an import-
ant tool for examining how therapies work, and they pro-
vide an appropriate way to identify the active elements of
interventions [48]. With this study design, multicomponent
treatments are decomposed, and the complete intervention
is compared to an intervention in which a component is
eliminated (dismantling studies) or to an intervention with
an addition component (additive studies; [49]). There are
few studies with a dismantling design in interventions for
depression [50]. A recent comprehensive systematic review
and meta-analysis of dismantling studies of psychotherapies
for adult depression included only 16 studies, none with an
Internet-based intervention [15].
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Our research group has developed an Internet-based
cognitive-behavioral treatment protocol that also in-
cludes PPs for patients suffering from depressive symp-
toms. It has shown its efficacy in different RCTs [51–
53]. The results show that this intervention is effective
overall, but we do not know the specific contribution of
each of its therapeutic components. Using a dismantling
strategy could help to identify the contribution of BA
and PPs (its main therapeutic components) to the thera-
peutic change. As a result, this information can contri-
bute to improving intervention programs for depression.
To the best of our knowledge no study with a dismant-
ling design exists with an Internet-based treatment proto-
col for depression, and even less so with the specific
objective of discovering the contribution of BA and PPs.
The objectives of the current study are to (a) evaluate
the efficacy at post-treatment and follow-ups (3, 6, and
12months) of a complete Internet-based protocol for
depressive symptoms (including motivation, cognitive
restructuring, BA, PPs, Relapse prevention), a protocol
for depressive symptoms without PPs, and a protocol for
depressive symptoms without a BA component, all of
them administered through the Internet to patients with
mild to moderate depressive symptoms; (b) analyze the
mediators of change in depressive symptoms; and (c)
study the acceptability and usability of the intervention.
Methods/design
Study design
The current study will be a three-armed, simple-blinded,
randomized controlled clinical trial with a dismantling
design. Specifically, three groups will be compared: a) an
Internet-based Global Protocol condition (IGc), b) an
Internet-based BA Protocol condition (IBAc), and c) an
Internet-based PPs Protocol condition (IPPc). At this
moment, the study is ongoing, and we are in the partici-
pant recruitment phase. Participants will be randomly
allocated to one of the three experimental conditions.
Randomization will be stratified by levels of depression
severity (mild to moderate).
We will carry out block randomization within each
stratum to certify that all levels of depression are balanced
across the three experimental conditions. The study follows
the CONSORT statement (Consolidated Standards of
Reporting Trials) [54, 55], CONSORT-EHEALTH [56] and
SPIRIT guidelines (Standard Protocol Items: Recommen-
dations for Interventional Trials) [57, 58]. Participants’
assessments will be performed at pre-treatment and post-
treatment. Furthermore, there will be three follow-ups: at 3,
6, and 12months. Figure 1 shows the study flowchart.
Participants, recruitment and eligibility criteria
The RCT will be carried out at the Emotional Disorder
Clinic in Universitat Jaume I. Participants will be adult
volunteers with mild to moderate depressive symptoms
(from 14 to 28 on the Beck Depression Inventory-II,
BDI-II) [59].
Participants will be recruited through the website spe-
cially developed for this aim, emails, phone calls, or per-
sonal visits, and they will be attended to by a clinician.
Once a potential participant has been identified by the
clinical psychologist, s/he will be informed about all the
characteristics of the study. Any questions or doubts will
be clarified in order to ensure that participants have
understood all the information correctly. Those who are
interested in participating will sign the informed con-
sent. Furthermore, an independent researcher will assess
whether they meet all the inclusion criteria.
To participate in the study, participants must meet
these inclusion and exclusion criteria. The inclusion cri-
teria are: a) 18 to 65 years old; b) able to read and under-
stand Spanish; c) access to Internet; d) knowing how to
use the Internet; and e) experiencing mild to moderate
depressive symptoms (from 14 to 28 on the Beck
Depression Inventory-II [BDI-II]). Exclusion criteria
include: a) receiving a psychological intervention; b) suf-
fering from a severe Axis I mental disorder: alcohol and/
or substance dependence disorder, bipolar disorder,
psychotic disorder, or dementia; c) having ideation or a
significant plan for suicide (assessed by the MINI and
item 9 of the BDI-II). Receiving pharmacological medi-
cation while participating in the study is not an exclu-
sion criterion. However if the patient has an increase in
the pharmacological treatment, s/he will be excluded
from the study analysis. Nevertheless, a reduction in the
medication does not imply exclusion from the study. We
will offer alternative treatments to the participants who
do not meet the criteria for the present study.
If the participants fulfill the eligibility criteria, they will
be randomized to one of the three experimental condi-
tions by an independent investigator who will not have in-
formation about the RCT’s characteristics. Randomization
will be performed using a weighted random number se-
quence generated by a computer, in order to have a homo-
geneous distribution across the three conditions. The
study researchers will be informed about the allocation
schedule via telephone call. Before the allocation to one of
the three interventions, the patients will agree to partici-
pate without having the information about which inter-
vention they will be receive. Nevertheless, for pragmatic
reasons, researchers and patients will not be blind to the
intervention conditions. At any time during the study, the
participants will be allowed to drop out of the intervention
without giving any reasons.
Ethics
This study will be carried out in conformity with the study
protocol and the Declaration of Helsinki. Furthermore, it
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will guarantee the confidentiality and security of the data
following the guidelines set forth in the current laws and
data protection regulations: The General Data Protection
Regulation, agreed upon by the European Parliament
and Council in April 2016. Moreover, all important
EU legislation and international documents on privacy
will be followed.
All participants will be volunteers. When the study has
been explained to them, they will sign the online informed
consent to participate. Qualified clinical personnel will con-
duct the clinical assessment of the participants as part as
the recruitment process. In the same way, all the tasks
involving the participants will be performed by qualified,
expert professionals (Clinical Psychology PhD). The assess-
ment protocol is composed of standardized instruments
(semi-structured interviews and questionnaires). Likewise,
treatment protocols are based on empirically-validated
treatments from the Task Force on the Promotion and
Dissemination of Psychological Procedures of the American
Psychological Association [60].
Data protection is an important aspect of the project.
To access the Internet platform, the participants will have
a unique username and password combination. Further-
more, the platform will be available on a 24/7 basis. More-
over, the transferred data will be secured using AES
encryption (AES-256; Advanced Encryption Standard).
The study policies do not differ from those used in other
clinical trials focused on the treatment of depression through
the Internet, and so no special difficulties are expected.
The study has been approved by the Ethics Committee
of University Jaume I (Castellon, Spain, approval num-
ber: 4/2017). The trial is registered at clinicalstrials.gov
as NCT03159715.
Important protocol modifications will be communi-
cated to relevant parties (i.e., trial participants, trial
registries, journals, ethical committee and researchers).
Fig. 1 Study design
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Interventions
Internet-based global protocol condition (IGc)
We have developed a manualized intervention protocol
for depressive symptoms called Sonreír es Divertido
(Smiling is Fun in English). It is an Internet-based pro-
gram developed in a European project: Online predictive
tools for intervention in mental illness [51]. Smiling is
Fun includes the psychological treatment components
that are traditionally incorporated in evidence-based in-
terventions for depression: Motivation for change,
Psychoeducation, Cognitive Therapy, BA, and Relapse
Prevention. The program also incorporates a PPs com-
ponent, offering tools to improve positive affect and
promote strengths.
The intervention program includes eight modules:
four CBT based modules; three PPs based modules, and
one Relapse prevention module.
Regarding the CBT modules: 1) “Motivation for
change”, 2) “Understanding emotional problems”, 3)
“Learning to move on”, and 4) “Learning to be flexible”,
their main objectives, respectively, are: a) To analyze
both the advantages and disadvantages of changing their
behaviors, feelings, and thoughts; b) To offer informa-
tion to help the patient to understand the characteristics
of the emotional problems; c) To explain the importance
of being involved in life and acquiring an appropriate
activity level; and d) To teach the patients how to
think in a more flexible manner.
In the case of the PPs modules, designed to promote
positive affect, well-being, and psychological strengths:
5) “Learning to enjoy”, 6) “Learning to live”, 7) “Living
and learning”, their principal objectives are, respectively:
a) To “savor” and enjoy positive life experiences; b) To
do activities linked to their own goals and values and
learn how to identify their psychological strengths; c) To
know how to improve their psychological strengths and
start working toward the future.
At the end of the program, there is a Relapse preven-
tion component in module 8) “From now on, what
else…?”, whose objectives are: a) To review what has
been learned in each module; b) To learn that finishing
the program does not mean no longer practicing the
strategies learned, and that it is the beginning of each
patient’s path; and d) To invite them to think about what
they would like their future life to be like.
Internet-based BA protocol condition (IBAc)
This intervention protocol has these CBT components
from the original protocol (IGc) explained above: Motiv-
ation for change, Psychoeducation, Cognitive Flexibility,
BA, and Relapse Prevention. The PPs component is not
included in this protocol.
The BA component in this protocol teaches the same
things as the BA component in IGc.
Internet-based PPs protocol condition (IPPc)
This intervention protocol has these CBT components
from the original protocol (IGc) explained above: Moti-
vation for change, Psychoeducation, Cognitive Flexibility,
and Relapse Prevention. The BA component is not
included in this protocol.
The PPs component in this protocol teaches the same
things as the PPs component in IGc.
Table 1 showed the structure of the IBAc and IPPc.
It is important to mention that the three protocols
have the same number of modules (eight) and a similar
number of words: IGc: 35.123; IBAc 35.492 and IPPc:
39.002 (M: 36541; SD: 2139.003).
The three treatment protocols include a “Welcome”
module that explains information about the treatment
protocol and its purposes. Furthermore, it explains the
main recommendations for obtaining the most benefit
from it. After this “Welcome” module, the patients access
the pre-treatment assessment online questionnaires. After
the pre-treatment assessment, participants start the inter-
vention modules. Table 2 shows the structure of each
module. The modules include exercises to practice each
technique and skill. Furthermore, at the end of each
Table 1 The structure of the IBAc and IPPc
Internet-based BA Protocol condition (IBAc) Internet-based PPs Protocol condition (IPPc)
Modules/ Therapeutic component Modules/ Therapeutic component
1.“Motivation for change”/ Motivation 1.“Motivation for change”/ Motivation
2.“Understanding emotional problems”/ Psychoeducation 2.“Understanding emotional problems”/ Psychoeducation
3.“Learning to be flexible”/ Cognitive Flexibility 3.“Learning to be flexible” / Cognitive Flexibility
4.“Learning to be active”/ BA 4.“Getting involved with life”/ PPs
5.“My significant activities”/ BA 5.“Enjoying life”/ PPs
6.“Seeking support to be active”/ BA 6.“Accepting life”/ PPs
7.“Keeping my life active”/ BA 7.“Achieving a full life”/ PPs
8.“From now on, what else…?”/Relapse prevention 8.“From now on, what else…?”/Relapse prevention
Note. Modules 1, 2, 3, and 8 are included in all three conditions
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module, there is a post-module assessment to evaluate
depression, anxiety, and positive/negative affect. When
participants complete the eight treatment modules, they
perform the post-treatment assessment, which is also
integrated in the web system (the same self-report ques-
tionnaires as in the pre-treatment assessment, plus the
treatment satisfaction scale).
An important function of the program is that the
therapists have access to all the information participants
provide during the treatment, so that if the patient’s con-
dition gets worse they can receive an alert. These alerts
are generated by the system when a high risk of suicide
is detected. Then, an email is sent to the clinical team so
that the therapist can contact the patients and make
better decisions to protect and help them.
Regarding the use of the intervention, participants will
progress sequentially through the program at their own
rhythm, but they will be informed that they will receive
the most benefit from the intervention if they do about
one module every 2 weeks. This is the time stipulated to
complete each module and practice the techniques and
strategies learned. The participants will be informed that
they have a maximum of 16 weeks to complete all eight
modules. As the intervention progresses, when they
finish one module, they will be allowed to look it over
again if they so desire.
All the modules will be on a web platform developed
by our research group (https://www.psicologiaytecnolo-
gia.com/). It was designed for optimal use on a tablet or
a PC and to optimize the understanding of the modules’
content using different multimedia elements such as
audio, vignettes, video, etc. The web platform has
different transversal tools that accompany the person
throughout the entire intervention process (Table 3).
Support
In the intervention conditions, the participants will
receive human and ICT support.
Regarding human support, one trained predoctoral
student in our group will make several brief phone calls
at four points in time:
(a) An initial telephone session: to explain the
characteristics of the RCT to the participant
and administer the clinical diagnostic interview
and find out whether s/he fulfills the inclusion
criteria.
(b) An initial phone call in the “Welcome” module:
encouraging patients to start the program, do one
module every 2 weeks, and do the homework tasks
in each module. This phone call will take place
when the participants do the pre-treatment
assessments.
(c) One brief phone call (maximum of 10 min) when the
participants reach the mid-point of the intervention
(module 4): 1) to ask the participants about any
doubts or difficulties regarding the use of the
program and help them; 2) to remind them that
they can review the content of each module; 3) to
emphasize the importance of doing the tasks in
each module and practice the strategies they learn;
4) to motivate patients to continue with the
program and positively reinforce them for engaging
in the intervention; and 5) to remember that the
best way to experience the intervention is by doing
one module every 2 weeks.
(d) A final phone call after the post-assessment: to ask
them their qualitative opinion about the intervention
and remind participants that they will be allowed to
use the intervention program any time they want to
during the study period, and that we will contact
them to do the follow-up assessment.
Table 2 Structure of each module
Structure of each module
1. Questions related to the previous module
2. Specific contents of the module
3. Exercises related to the content of the module
4. Homework tasks telling them to work on what was
presented in the module
5. Post module assessment: depression, anxiety, positive
and negative affect
Table 3 Transversal tools of the web platform
“Home” This tool is the starting point of the protocol, appears on the main menu, and is used to access the other sections of the
protocol. It also shows the progress through the treatment.
“Calendar” In this section, the participant can know where he/she is in the program. This tool also shows the days on which the
participant has accessed the program, as well as both pending and achieved tasks.
“Review” This section is used by participants to review the treatment modules already completed. This tool allows them to have
access to the different modules as often as they wish.
“How am I” This section offers several graphs that make it possible to monitor the participant’s progress. It provides feedback to
participants about their activity level, emotional distress, and positive and negative emotionality.
“Diary register” The objective of the “Diary register” is to collect data every day about different variables (activity level, emotional distress,
positive and negative emotionality) and show them graphically on the “How am I” tool.
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ICT support will consist of multiple-choice questions
about the module’s contents in order to provide the par-
ticipant with the correct feedback for their responses
and a detailed explanation. Furthermore, the participants
will receive an automated email encouraging them to
continue with the modules if they have not accessed the
program for a week. In addition to this automated
support, the program offers continued feedback to users
through the transversal tools described earlier.
Instruments
Diagnostic interview
Mini International Neuropsychiatric Interview Version
5.0.0 (MINI) [61]. It is a structured diagnostic interview
for DSM-IV and ICD-10 psychiatric disorders. It was
designed to be used by clinicians or even by nonclinical
personnel after brief training, and it has an adminis-
tration time of approximately 15 min. The MINI has
excellent interrater reliability (K = .88–1.00), and it has
been translated and validated in Spanish [62].
Primary outcomes
Depression Beck Depression Inventory (BDI-II) the
BDI-II is a 21-item self-report multiple-choice inventory
that is widely used to detect and assess the severity of
depressive symptoms. The items, scored on a scale from
0 to 3, cover the different symptoms characterizing
major depression disorder in the DSM-IV [57], such as
sadness, pessimism, past failure, loss of pleasure, guilty
feelings, punishment feelings, suicidal thoughts or
wishes, etc. The scores on the scale range from 0 to 63.
The internal consistency of the BDI-II is high (alpha =
0.76 to 0.95), and for the Spanish version of the instru-
ment (alpha = 0.87), for both general and clinical popula-
tions (alpha = 0.89) [63].
Positive and negative emotionality Positive and Nega-
tive Affect Scale (PANAS) the PANAS [64] consists of
two 10-item mood scales that assess two independent
dominant dimensions of affective structure: positive
affect (PA) and negative affect (NA). Each scale ranges
from 10 to 50. The PANAS is brief, reliable, and has
shown excellent internal consistency (alpha between
0.84 and 0.90) and convergent and divergent validity.
The Spanish version has also shown high internal
consistency (α = 0.87 and 0.89 for PA and NA in men,
respectively, and α = 0.89 and 0.91 for PA and NA in
women, respectively [64].
Secondary outcomes and post-module measures
Connor-Davidson Resilience Scale (CD-RISC) the
CD-RISC [65] is a brief scale that consists of 25 items.
The person must indicate to what extent each statement
has been true for him/her in the past month on a scale
from 0 to 4, where 0 =“has not been true at all” and
4=“true almost always”. The total scores range from 0 to
100; higher scores indicate greater resilience. Previous
studies have shown that the CD-RISC has good internal
consistency (Cronbach alpha above 0.70) [65].
Overall Depression Severity and Impairment Scale
(ODSIS) The ODSIS [66] is a brief, 5-item self-report
measure for assessing the frequency and severity of depres-
sion, as well as functional impairments in pleasurable activ-
ities, work or school interference, and social relationship
interference associated with depression. The items are
scored on a scale from 0 to 4, and they function
similarly across clinical and nonclinical samples. The
ODSIS has shown excellent internal consistency
(Cronbach’s alpha between .91 and .94) and good con-
vergent/discriminant validity [66].
Perceived Stress Scale (PSS) The PSS [67] is a self-re-
port instrument that assesses the level of stress perceived in
the past month. It consists of 14 items scored on a scale
ranging from 0 (never) to 4 (very often). The total score
range varies between 0 (minimum perceived stress) and 56
(maximum perceived stress). In the present study, a 4-item
PSS (PSS-4) was used. This PSS-4 was introduced as a brief
version for situations requiring a very short scale or
telephone interviews [68]. It has been validated in
different studies, showing an internal consistency re-
liability of 0.76–0.82 [69].
Overall Anxiety Severity and Impairment Scale
(OASIS) The OASIS [70] is a 5-item self-report measure,
rated from 0 to 4, that can be used to assess the frequency
and severity of anxiety disorders, multiple anxiety dis-
orders, and subthreshold anxiety symptoms. The scale
also provides measures of functional impairments in
pleasurable activities, work or school interference, and
social relationship interference associated with anxiety
symptoms. The OASIS has demonstrated strong psy-
chometric properties with good internal consistency
(alpha = 0.80), test-retest reliability (K = 0.82), and
convergent validity [70–72].
Quality of life Inventory (QLI) The QLI [73] is a brief
self-report questionnaire used to measure the perceived
quality of life in different areas. The inventory consists
of 10 items scored on a scale ranging from 1 to 10. It is
calculated by averaging the 10 items, and the maximum
score is 10. The QLI assesses aspects related to physical
well-being, psychological well-being, self-care and inde-
pendent functioning, occupational functioning, interper-
sonal functioning, social emotional support, community and
services support, personal fulfillment, spiritual fulfillment,
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and overall quality of life. The QLI has shown excellent
internal consistency (between 0.90 and 0.92), test-retest
reliability (0.87), and discriminant validity. The Spanish
validation of the QLI [74] has also demonstrated good
test-retest reliability (0.89) and discriminant validity.
Pemberton Happiness Index (PHI) The PHI [75] is a
brief instrument to measure different domains of well-be-
ing (i.e., general, hedonic, eudemonic, and social). It con-
tains 11 items rated on a scale where 0 = strongly disagree
and 10 = strongly agree. The reliability of this scale is quite
satisfactory (alpha = 0.89) [75].
Enjoyment Orientation Scale (EOS) The EOS [76] is a
6-item self-report measure that assesses the extent to which
participants try to be receptive and make an effort to be
engaged in pleasant things (anticipatory pleasure). This
scale is very related to the behavioral activation system that
is believed to regulate appetitive motives. The items on the
EOS are rated on a Likert scale from 1 (“strongly disagree”)
to 7 (“strongly agree”) [76].
Environmental Reward Observation Scale (EROS)
The EROS [77] is a brief, reliable, and valid measure
of environmental reward. It consists of a 10-item
Likert measure rated from 1 (“strongly disagree”) to 4
(“strongly agree”), with the total score representing the
sum of the 10 items. The Spanish EROS is internally
consistent (alpha = 0.86) and valid [77].
Acceptance, satisfaction and usability outcomes Ex-
pectation of treatment scale and opinion of treatment
scale these two scales are adapted from Borkovec and Nau
[78]. Each scale contains 5 items, regarding whether the
treatment is logical, treatment satisfaction, the treatment’s
utility for other psychological problems, and the treat-
ment’s usefulness for the patient’s specific problem. The
expectation scale is administered at the post-module 2 as-
sessment, when the treatment has been explained to the
participants, and the opinion scale is administered at the
end of the treatment, with the aim of assessing satisfac-
tion. Our group has used this questionnaire in several re-
search studies [51, 79].
System Usability Scale (SUS)
The SUS [80] is a brief, reliable scale for measuring
the usability of a program. It consists of a 10-item ques-
tionnaire with 5 response options, from 0 (“strongly dis-
agree”) to 4 (“strongly agree”). Its purpose is to collect
the user’s opinion about the usability of the system, and
unacceptable usability may indicate that the user has
had technical difficulties with the program. The SUS
adjective rating scale (from “Worst imaginable” to “Best
imaginable”) will be used to provide a qualitative com-
parison of usability scores [81].
The study measures and area and time of assessment
are summarized in Table 4.
Sample size and power calculations
The a priori sample size determination was performed
based on the main objective of this investigation. Follow-
ing Cohen’s (1988) guidelines, we assumed a proportion of
explained variance of low magnitude for the interaction
between the type of intervention and the measurement
occasion, that is, 0.01. For a significance level of 5%, statis-
tical power of 80%, assumed sphericity, and correlation of
.7 between repeated measures (following Rosenthal’s 1991
recommendation), the total sample size needed was 147
participants (49 per intervention group). To this figure, an
additional 30% was added to anticipate potential dropouts.
Therefore, the total sample size of the study was 192 par-
ticipants (64 per intervention group). Sample size cal-
culations were carried out with the statistical program
G*Power 3.1.9.2 [82].
Statistical analysis
Per protocol and Intention-to-treat (ITT) analyses will
be performed, following the CONSORT and CONSORT-
eHealth recommendations [56, 83]. Between-group dif-
ferences in baseline clinical and socio-demographic
characteristics will be explored using analysis of variance
(ANOVA) for continuous data, and chi-square tests (χ2)
for categorical variables. Both normality and multinor-
mality assumptions will be assessed by applying the
Kolmogorov-Smirnov (K-S) test, skewness and kurtosis
indexes, and histogram and Q-Q plots. Levene’s test will
be conducted to check homoscedasticity assumptions
for equality of variances, and Mauchly’s test to explore
sphericity assumptions. Missing data patterns will be
assessed, and whether missing data are missing com-
pletely at random (MCAR) will be checked with Little’s
MCAR test [84]. The ITT principle will be applied for
primary and secondary outcomes collected at post-treat-
ment, and at the 3, 6, and 12-month follow-ups. In this
regard, the maximum likelihood (ML) method using the
Expectation Maximization (EM) algorithm will be used
to deal with missing data, due to its flexibility in
repeated-measures ANOVAs in handling missing data
appropriately (i.e., [85, 86]. Nevertheless, several ap-
proaches will also be considered and assessed using
sensitivity analyses in order to apply the most robust
and adequate method based on both missing data
patterns and literature recommendations (i.e., [87, 88].
Repeated analysis of variance (rm-ANOVA) will be per-
formed to explore the main and interaction effects of
the treatments on all the primary and secondary out-
comes. Significant effects will be followed up by pairwise
comparisons, such as the Tukey procedure when the
homoscedasticity assumption is met, and the
Games-Howell procedure if this assumption is not met.
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Effect sizes (Cohen’s d) and their respective 95% confi-
dence intervals (95% IC) will be calculated and reported
for within- and between-group comparisons, according
to authors’ recommendations [89–91]. In addition to
ITT analyses, per protocol analyses will also be con-
ducted. It is true that these analyses suffer from selection
bias, but they will allow us to reach conclusions about
the efficacy of the treatment in patients who complete all
the intervention modules [92].
For acceptability and usability measures, data analysis
will be based on completers. Separate multivariate ana-
lysis of variance (MANOVA) for expectations, satisfac-
tion, and usability will be performed, where all items are
entered into the MANOVA as dependent variables, and
the experimental group as a fixed factor (independent
variable).
Finally, multiple regression analysis and mediation
analysis will be conducted to explore potential predictors
and mediators of depressive symptoms. Mediation ana-
lyses will be performed through bootstrap regression
analysis using the Preacher and Hayes (2004) approach.
All statistical analyses will be conducted using IBM SPSS
Statistics for Windows, version 23.
We will review the state of the art analytical methodology
for RCT before performing the analyses of the data, in
order to use the best statistical analysis procedure.
Thus, there may be some variations in the statistical
analysis procedures.
Discussion
This paper describes the protocol for a randomized con-
trolled dismantling study of an Internet-based intervention
for patients with mild to moderate depressive symptoms.
One of the main aims of this study is to evaluate the
efficacy of a complete Internet-based intervention for
depressive symptoms (including motivation, cognitive re-
structuring, BA, PPs, and Relapse prevention), the same
Internet-based intervention without the PPs component,
and the same Internet-based intervention without the BA
component, all of them administered over the Internet to
patients with mild to moderate depressive symptoms.
These three intervention protocols with different thera-
peutic components will be tested in order to explore the
specific contribution of each therapeutic component
involved in the treatment of depression and better
understand how and why therapies lead to change [20].
Although a large number of psychological interventions
have been shown to be effective in the treatment of
depression, the specific influence of each therapeutic com-
ponent is still unknown [15]. Thus, it is crucial to delimit
the influence that the specific therapeutic components of
psychological interventions can have.
Furthermore, current psychological treatments for de-
pression focus largely on reducing excesses in negative
affect rather than on specifically improving deficits in
positive affect and well-being [36, 93]. It is well known
that depression often involves low levels of positive
Table 4 Study measures, assessment area and time of assessment
Outcomes Concept Instrument Time of assessment
BL Post-T Post-M FUPs (3, 6, 12)
Diagnostic interview Diagnosis MINI Neuropsychiatric Interview X X X
Primary Depression BDI-II X X X
Positive and Negative affect PANAS X X X X
Secondary Resilience CD-RISC X X X
Depression ODSIS X X X X
Perceived Stress PSS X X X
Anxiety OASIS X X X X
Quality of life QLI X X X
- Well-being PHI X X X
- Anticipatory pleasure EOS X X X
- Environmental reward EROS X X X
Acceptance, satisfaction and usability outcomes
- Expectation of treatment Expectation of Treatment Scale X
- Opinion of treatment Opinion of Treatment Scale X
- Usability SUS X
Note: BL Baseline, Post-T Post-treatment, Post-M Post Module, FUPs (3,6,12) 3, 6, and 12-month follow-ups, BDI-II Beck Depression Inventory-II, CD-RISC Connor-
Davidson Resilience Scale, PANAS Positive and Negative Affect Scale, ODSIS Overall Depression Severity and Impairment Scale, PSS Perceived Stress Scale, OASIS
Overall Anxiety Severity and Impairment Scale, QLI Quality of Life Index, PHI Pemberton Happiness Index, EOS Enjoyment Orientation Scale, EROS Environmental
Reward Observation Scale, SUS System Usability Scale
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affect [22, 93] that increase the severity of the problem
[94]. Furthermore, people with high levels of positive
affect tend to have better well-being and psychological
and physical health [95].
In this regard, it is important to include positive affect
as an essential target of the treatment by considering
well-being and positive functioning to be core elements
of the intervention.
Recent literature shows that PPs techniques might
have an impact on the decline in clinical symptomato-
logy [22, 36, 96, 97]. These PPs (Well-being Therapy;
Quality of Life therapy; Positive Psychotherapy, and
Strengths based Counseling) are based on the hypothesis
that it is possible to treat depression not only by focus-
ing on decreasing the negative symptoms, but also by
directly and primarily building positive emotions and
promoting psychological strengths and a meaningful life
[27, 31]. Recent findings suggest that explicitly focusing
on positive emotions efficiently improves depressive
symptoms and helps to achieve more profound change
in positive functioning measures [98–100]. However, the
specific contribution of these PPs in the treatment of
depression has scarcely been studied. In fact, in a recent
comprehensive systematic review and meta-analysis of
dismantling studies of psychotherapies for adult depres-
sion, no study is included that dismantles an inter-
vention with a PPs-based component, and none with an
Internet-based intervention [15].
The dismantling design of the current study will allow
us to explore the contribution of each main treatment
component. More specifically, it will allow us to know
how PPs and emotional regulation strategies centered on
positive affect work, resulting in a significant shift to
optimize treatments for depression. In addition, with the
current study, it will be possible to analyze the mediators
of changes in depressive symptoms and the acceptability
of each intervention.
Moreover, this study is consistent with one of the most
important challenges within the field of the treatment of
depression, which is the design of new ways to apply
treatments to maximize their therapeutic efficiency.
Undoubtedly, the use of technology and the Internet can
help to achieve this goal and contribute to the dissemi-
nation and accessibility of evidence-based treatments. Fur-
thermore, another advantage of the Internet-based
interventions is the possibility of making online assess-
ments. Research results encourage the use of online ques-
tionnaires because they offer advantages over traditional
data collection strategies [101, 102]. Some of these advan-
tages are that missing data can be handled better, and the
assessment is easy and immediate [101] and can take place
right after the patients finish a psychological component.
This could make it easier to know the specific contribution
of each component throughout the intervention process.
In sum, this study has several strengths. To the best of
our knowledge, this is the first randomized dismantling
intervention study for depression with the aim of explor-
ing the contribution of a PPs component and the BA
component in an Internet-based intervention. The three
protocols are online interventions, helping to reach
many people who need psychological treatments and
would not otherwise have access to them. Furthermore,
acceptability and usability measures will be included in
order to assess the intervention’s feasibility and accept-
ance, in addition to an efficacy study. Finally, potential
mediator mechanisms will be explored to identify the
variables that lead to changes in depressive symptoms.
We are aware that this study has limitations. One of
them is that the number of BA and PPs modules in the
IBAc and IPPc is higher than in the IGc, although the
clinical content is the same in the global protocol and in
the protocols for the BA and PPs components. The
reason for this is that the three protocols contain the
same total number of modules (8 modules per each) and
a similar number of words. We give all the patients the
same amount of time to do the intervention to try to
control this. Another limitation is that the dropout rates
are expected to be high (around 30%) [103]. Efforts will
be made to minimize the dropout rates by providing
ICT and human support. Approaches to handling
missing data will be considered and assessed using
sensitivity analyses in order to apply the most robust
and adequate method, based on both the missing data
patterns and recommendations found in the literature
(i.e., [87, 88]. In addition, difficulties in the recruit-
ment phase will be considered.
In summary, this study extends the current literature
about Internet-based interventions for depression. If
positive results are achieved, they may have an important
impact by providing better knowledge about the core
elements of evidence-based treatments for depression.
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